aripiprazole - European Medicines Agency - Withdrawals of Application - Medicinal Products for Human Use - Abilify

Otsuka Pharmaceutical Europe Ltd withdraws its application for an extension of indication for Abilify (aripiprazole)

abrir aquí para acceder al documento EMEA completo:
European Medicines Agency - Withdrawals of Application - Medicinal Products for Human Use - Abilify